These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 28862072

  • 1. Intranasal delivery of tapentadol hydrochloride-loaded chitosan nanoparticles: formulation, characterisation and its in vivo evaluation.
    Javia A, Thakkar H.
    J Microencapsul; 2017 Nov; 34(7):644-658. PubMed ID: 28862072
    [Abstract] [Full Text] [Related]

  • 2. Bio-fabrication and statistical optimization of polysorbate 80 coated chitosan nanoparticles of tapentadol hydrochloride for central antinociceptive effect: in vitro-in vivo studies.
    Patil GB, Surana SJ.
    Artif Cells Nanomed Biotechnol; 2017 May; 45(3):505-514. PubMed ID: 27017892
    [Abstract] [Full Text] [Related]

  • 3. Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery.
    Rukmangathen R, Yallamalli IM, Yalavarthi PR.
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1342-1350. PubMed ID: 31094571
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Formulation, development and optimization of raloxifene-loaded chitosan nanoparticles for treatment of osteoporosis.
    Saini D, Fazil M, Ali MM, Baboota S, Ali J.
    Drug Deliv; 2015 Aug; 22(6):823-36. PubMed ID: 24725026
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting.
    Wang X, Chi N, Tang X.
    Eur J Pharm Biopharm; 2008 Nov; 70(3):735-40. PubMed ID: 18684400
    [Abstract] [Full Text] [Related]

  • 8. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
    Bagre AP, Jain K, Jain NK.
    Int J Pharm; 2013 Nov 01; 456(1):31-40. PubMed ID: 23994363
    [Abstract] [Full Text] [Related]

  • 9. "Application of Box-Behnken design for optimization and development of quetiapine fumarate loaded chitosan nanoparticles for brain delivery via intranasal route* ".
    Shah B, Khunt D, Misra M, Padh H.
    Int J Biol Macromol; 2016 Aug 01; 89():206-18. PubMed ID: 27130654
    [Abstract] [Full Text] [Related]

  • 10. Biopharmaceutical Potential of Selegiline Loaded Chitosan Nanoparticles in the Management of Parkinson's Disease.
    Rukmangathen R, Yallamalli IM, Yalavarthi PR.
    Curr Drug Discov Technol; 2019 Aug 01; 16(4):417-425. PubMed ID: 29669501
    [Abstract] [Full Text] [Related]

  • 11. Development, optimisation and evaluation of chitosan nanoparticles of alendronate against Alzheimer's disease in intracerebroventricular streptozotocin model for brain delivery.
    Zameer S, Ali J, Vohora D, Najmi AK, Akhtar M.
    J Drug Target; 2021 Feb 01; 29(2):199-216. PubMed ID: 32876502
    [Abstract] [Full Text] [Related]

  • 12. Preparation of Chitosan Okra Nanoparticles: Optimization and Evaluation as Mucoadhesive Drug Delivery System.
    Brar V, Kaur G.
    Pharm Nanotechnol; 2018 Feb 01; 6(3):180-191. PubMed ID: 30101724
    [Abstract] [Full Text] [Related]

  • 13. A Novel Delivery Method of Cyclovirobuxine D for Brain-Targeting: Chitosan Coated Nanoparticles Loading Cyclovirobuxine D by Intranasal Administration.
    Wei H, Lai S, Wei J, Yang L, Jiang N, Wang Q, Yu Y.
    J Nanosci Nanotechnol; 2018 Aug 01; 18(8):5274-5282. PubMed ID: 29458577
    [Abstract] [Full Text] [Related]

  • 14. Chitosan nanoparticles for intranasal delivery of olmesartan medoxomil: Pharmacokinetic and pharmacodynamic perspectives.
    Hassan RH, Gad HA, El-Din SB, Shaker DS, Ishak RAH.
    Int J Pharm; 2022 Nov 25; 628():122278. PubMed ID: 36243325
    [Abstract] [Full Text] [Related]

  • 15. Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting.
    Fazil M, Md S, Haque S, Kumar M, Baboota S, Sahni JK, Ali J.
    Eur J Pharm Sci; 2012 Aug 30; 47(1):6-15. PubMed ID: 22561106
    [Abstract] [Full Text] [Related]

  • 16. Brain delivery of buspirone hydrochloride chitosan nanoparticles for the treatment of general anxiety disorder.
    Bari NK, Fazil M, Hassan MQ, Haider MR, Gaba B, Narang JK, Baboota S, Ali J.
    Int J Biol Macromol; 2015 Nov 30; 81():49-59. PubMed ID: 26210037
    [Abstract] [Full Text] [Related]

  • 17. Formulation and corneal permeation of ketorolac tromethamine-loaded chitosan nanoparticles.
    Fathalla ZM, Khaled KA, Hussein AK, Alany RG, Vangala A.
    Drug Dev Ind Pharm; 2016 Nov 30; 42(4):514-24. PubMed ID: 26407208
    [Abstract] [Full Text] [Related]

  • 18. Pharmacological evaluation of nasal delivery of selegiline hydrochloride-loaded thiolated chitosan nanoparticles for the treatment of depression.
    Singh D, Rashid M, Hallan SS, Mehra NK, Prakash A, Mishra N.
    Artif Cells Nanomed Biotechnol; 2016 May 30; 44(3):865-77. PubMed ID: 26042481
    [Abstract] [Full Text] [Related]

  • 19. Development and optimization of in-situ gel containing chitosan nanoparticles for possible nose-to-brain delivery of vinpocetine.
    Hard SAAA, Shivakumar HN, Redhwan MAM.
    Int J Biol Macromol; 2023 Dec 31; 253(Pt 6):127217. PubMed ID: 37793522
    [Abstract] [Full Text] [Related]

  • 20. Brain pharmacokinetics of neurotoxin-loaded PLA nanoparticles modified with chitosan after intranasal administration in awake rats.
    Zhang X, Liu L, Chai G, Zhang X, Li F.
    Drug Dev Ind Pharm; 2013 Nov 31; 39(11):1618-24. PubMed ID: 24087853
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.